Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds
2011

Anticancer Compounds from Psoralea corylifolia Seeds

publication Evidence: moderate

Author Information

Author(s): Wang Yi, Hong Chengtao, Zhou Chenguang, Xu Dongmei, Qu Hai-bin

Primary Institution: Zhejiang University

Hypothesis

This study aimed to screen and identify bioactive compounds with anticancer activity from the seeds of Psoralea corylifolia L.

Conclusion

Psoralen and isopsoralen from Psoralea corylifolia L. seeds significantly inhibit cancer cell growth and induce apoptosis.

Supporting Evidence

  • Fraction IV from Psoralea corylifolia L. showed significant cytotoxicity on cancer cells.
  • Psoralen and isopsoralen exhibited dose-dependent anticancer effects on four cancer cell lines.
  • Apoptosis was significantly increased in tumor cells treated with psoralen and isopsoralen.

Takeaway

Researchers found that two compounds from a plant called Psoralea corylifolia can help fight cancer by making cancer cells die.

Methodology

The study involved extracting compounds from Psoralea corylifolia seeds and testing their effects on various cancer cell lines using MTT assays.

Limitations

The study primarily focused on in vitro effects, and further in vivo studies are needed to confirm the findings.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/ecam/nen087

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication